(Q48832920)

16 February 2018

title

Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain (English)

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

15 May 2024

0 references

H. Hays

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521784

15 May 2024

N. Hagen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521784

15 May 2024

M. Thirlwell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521784

15 May 2024

H. Dhaliwal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521784

15 May 2024

N. Babul

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521784

15 May 2024

Z. Harsanyi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521784

15 May 2024

A. C. Darke

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521784

15 May 2024

language of work or name

English

0 references

publication date

1 September 1994

1 reference

16 February 2018

15 September 1994

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7521784

full work available at URL

15 May 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

15 May 2024

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

15 May 2024

1 reference

16 February 2018

volume

74

1 reference

16 February 2018

issue

6

1 reference

16 February 2018

page(s)

1808-1816

1 reference

16 February 2018

Pharmacokinetics and Bioavailability of Hydromorphone Following Intravenous and Oral Administration to Human Subjects

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819940915%2974%3A6%3C1808%3A%3AAID-CNCR2820740625%3E3.0.CO%3B2-Y

Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva/plasma ratio and clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819940915%2974%3A6%3C1808%3A%3AAID-CNCR2820740625%3E3.0.CO%3B2-Y

Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819940915%2974%3A6%3C1808%3A%3AAID-CNCR2820740625%3E3.0.CO%3B2-Y

Putative role of hydromorphone metabolites in myoclonus

21 January 2018

4

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Clinical analgesic assay of repeated and single doses of heroin and hydromorphone

15 May 2024

7

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Relative Analgesic Potencies of Morphine and Hydromorphone in Postoperative Pain

15 May 2024

9

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Hydromorphone levels and pain control in patients with severe chronic pain.

15 May 2024

16

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Use of the subcutaneous route for the administration of narcotics in patients with cancer pain

15 May 2024

19

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjects

15 May 2024

23

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

The Edmonton staging system for cancer pain: preliminary report.

15 May 2024

26

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

The McGill Pain Questionnaire: Major properties and scoring methods

15 May 2024

27

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Analgesic response to single and multiple doses of controlled-release morphine tablets and morphine oral solution in cancer patients.

15 May 2024

28

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients

15 May 2024

29

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

The treatment of cancer pain

15 May 2024

31

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

The New England Journal of Medicine

15 May 2024

32

305

1417

Walsh

1981

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Controversies in the long-term management of analgesic therapy in patients with advanced cancer

15 May 2024

33

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions

15 May 2024

34

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

New clinical-practice guidelines for the management of pain in patients with cancer

15 May 2024

35

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Opioid hyperexcitability: the application of alternate opioid therapy

15 May 2024

36

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design

15 May 2024

39

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Breakthrough pain: definition, prevalence and characteristics

15 May 2024

40

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain.

15 May 2024

41

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Use of epidural opioid 'blockade' as an adjuvant diagnostic procedure

15 May 2024

42

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Can opiates relieve neuropathic pain?

15 May 2024

45

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Chronic use of opioid analgesics in non-malignant pain: report of 38 cases

15 May 2024

46

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Long-term oral opioid therapy in patients with chronic nonmalignant pain

15 May 2024

48

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

Long-term use of narcotic/antidepressant medication in the management of phantom limb pain

15 May 2024

52

1 reference

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(19940915)74:6%3C1808::AID-CNCR2820740625%3E3.0.CO;2-Y

15 May 2024

Identifiers

10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y

1 reference

16 February 2018

1 reference

16 February 2018